Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elsa Orvik"'
Publikováno v:
Tidsskrift for Omsorgsforskning, Vol 8, Iss 1, Pp 1-14 (2022)
Bakgrunn: Det er forventet at antall personer med komplekse helseproblem i primærhelsetjenesten vil øke i årene som kommer. Dette byr på vesentlige utfordringer når det gjelder å finne gode modeller for organiseringen i helsetjenestene. Hensikt
Externí odkaz:
https://doaj.org/article/8ab17ebf56f7479196a16204192b947a
Autor:
Morten W. Fagerland, Håvard Dalen, Svend Aakhus, Lars Gullestad, Odd Erik Johansen, Anne Pernille Ofstad, Elsa Orvik, Kåre I. Birkeland, Stig Urheim
Publikováno v:
Journal of Diabetes. 7:779-790
Background Subclinical left ventricular (LV) dysfunction is prevalent in type 2 diabetes (T2DM). As obesity has been proposed as one causal factor in the disease process, this could bias the reported prevalences. We wanted to characterize echocardiog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b3c5a0c343fb7621667227a26a4ea50
https://doi.org/10.1111/1753-0407.12239
https://doi.org/10.1111/1753-0407.12239
Autor:
Morten W. Fagerland, Anne Pernille Ofstad, Lars Gullestad, Kåre I. Birkeland, Elsa Orvik, Odd Erik Johansen, Geir R. Ulimoen
Publikováno v:
The Journal of International Medical Research
Objective To report the long-term impact on cardiovascular (CV) outcomes and mortality of a 2-year hospital-based multi-interventional care programme as compared with general practitioner (GP)-provided standard care. Methods Patients with type 2 diab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d56015bcdd9105560aa4a7e58ad70e
https://hdl.handle.net/10642/7290
https://hdl.handle.net/10642/7290
Autor:
Ragnhild Wergeland, Ø. Flesland, P. Aukrust, Lars Gullestad, Elsa Orvik, Odd Erik Johansen, Knut Endresen, Kåre I. Birkeland, Camilla Smith, Thor Ueland
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 67:306-316
Coronary artery disease (CAD) is prevalent in patients with type 2 diabetes mellitus (T2DM) and because it is often asymptomatic and extensive in comparison with CAD in subjects without diabetes, it represents a diagnostic challenge. The objective of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29edd74ad706320c1f4c8691b29854f
https://doi.org/10.1080/00365510601045088
https://doi.org/10.1080/00365510601045088
Autor:
Anne Pernille, Ofstad, Stig, Urheim, Håvard, Dalen, Elsa, Orvik, Kåre I, Birkeland, Lars, Gullestad, Morten, W Fagerland, Odd Erik, Johansen, Svend, Aakhus
Publikováno v:
Journal of diabetes. 7(6)
Subclinical left ventricular (LV) dysfunction is prevalent in type 2 diabetes (T2DM). As obesity has been proposed as one causal factor in the disease process, this could bias the reported prevalences. We wanted to characterize echocardiographic LV d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::400cf257bf6a83c5f74449c09925e144
https://pubmed.ncbi.nlm.nih.gov/25350248
https://pubmed.ncbi.nlm.nih.gov/25350248
Autor:
Svend Aakhus, Kåre I. Birkeland, Lars Gullestad, Stig Urheim, Elsa Orvik, Anne Pernille Ofstad, Morten W. Fagerland, Odd Erik Johansen
Publikováno v:
American heart journal. 168(3)
Background Patients with type 2 diabetes (T2D) are prone to develop preclinical myocardial dysfunction, but no single strategy to prevent progression to heart failure has been established. We aimed to assess whether intensified global cardiovascular
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98e505fe7bb4f51d3235773acffa6a66
https://pubmed.ncbi.nlm.nih.gov/25173538
https://pubmed.ncbi.nlm.nih.gov/25173538
Autor:
Bjørn Rino Torjussen, Kåre I. Birkeland, Beate Sørgård, Thor Ueland, Lars Gullestad, Odd Erik Johansen, Anders Palmstrøm Jørgensen, Elsa Orvik, Pål Aukrust
Publikováno v:
Journal of diabetes. 1(3)
Background: Diabetic foot ulcers (DFUs) are common complications of diabetes mellitus (DM), with a complex pathogenesis. Treatment is difficult and no single treatment with measurable clinical impact is available. In the present clinical pilot trial,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::324ba38dd1cd4fa01284661f8a3e1a4b
https://pubmed.ncbi.nlm.nih.gov/20923537
https://pubmed.ncbi.nlm.nih.gov/20923537
Autor:
Anne Pernille Ofstad, Svend Aakhus, Pål Aukrust, Morten W. Fagerland, Kåre I. Birkeland, Elsa Orvik, Lars Gullestad, Thor Ueland, Odd Erik Johansen, Knut Endresen
Publikováno v:
Cardiovascular Diabetology
Background Novel and robust cardiovascular (CV) markers are needed to improve CV morbidity and mortality risk prediction in type 2 diabetes (T2D). We assessed the long term predictive value of 4 novel CV risk markers for major CV events and mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76234027407cc91b75804bd5e63c721c